Condition: COPD Exacerbation · Oxygen Toxicity · Abdominal Obesity · Sponsor: François Lellouche
The main objective is to evaluate the FreeO2 device combined with noninvasive respiratory support technique for COPD patients and postoperative bariatric surgery patients. The main hypothesis is that FreeO2 device for oxygen therapy associated with NIV or nasal high flow oxygen therapy (NHFOT) allows to reach better oxygenation and avoid hypoxemia and hyperoxia.
This description comes directly from the study's public registry record.
François Lellouche, MD, PhD · 418-656-8711 · Francois.Lellouche@criucpq.ulaval.ca
Miguel Trottier, MD, CM · miguel.trottier.1@ulaval.ca
Always discuss trial participation with your own doctor first.
| Institut universitaire de Cardiologie et de Pneumologie - Université Laval | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04136717